Sign In
Home
Impavido - Miltefosine capsule
Get your patient on
Impavido - Miltefosine capsule
(Miltefosine)
Medication interactions
See all drug-to-drug interactions for this medication.
Check interactions
Prescribing info
PubMed™ news
Impavido - Miltefosine capsule prescribing information
Data source
Data source
Data Source
We receive information directly from the FDA and PrescriberPoint is updated as frequently as changes are made available
Report Adverse Event
Check medication interactions
Review interactions as part of your prescribing workflow
Check interactions
Impavido - Miltefosine capsule PubMed™ news
Last year
Publication date
Article Type
Format
5 articles
Reset Filters
5 most recent articles for Impavido - Miltefosine capsule
,
view all articles on PubMed™
Journal Article • 2026 May
Corrigendum to "Photodynamic therapy offers a novel approach to managing miltefosine-resistant cutaneous leishmaniasis" [Biomed. Pharmacother. 177 (2024) 116881].
Journal Article • 2026 May
p1/s1, a 3'-nucleotidase/nuclease, allows Leishmania major to circumvent host innate immune response mechanisms.
Journal Article • 2026 May
Host factors, inflammatory markers, and clinical outcomes of Naegleria fowleri meningoencephalitis.
Journal Article • 2026 May
Discovery of 4-carboxylate-1,2,3-triazine 1-oxide, their 1,2,3-triazine, and the 3,6-dihydro analogs, as new agents against Chagas diseases and Leishmaniasis.
Journal Article • 2026 May
Antileishmanial Evaluation and Mechanism of Action of Benzothiazole Derivatives with Aromatic/Heteroaromatic Hydrazone Moiety.
Show the latest PubMed™ articles for Impavido - Miltefosine capsule
I certify that I'm a U.S. healthcare provider
